Form 4: Beauty Health Co. Director Brian Miller Granted Significant Equity

Brian Christopher Miller, a director at The Beauty Health Company, was granted 73,051 restricted stock units, increasing his beneficial ownership to 243,035 shares.

Summary

• Brian Christopher Miller, a Director of The Beauty Health Company (SKIN), reported an acquisition of securities.
• On June 16, 2025, Mr. Miller was granted 73,051 shares of Class A Common Stock in the form of Restricted Stock Units (RSUs).
• Following this transaction, Mr. Miller's total beneficial ownership of Class A Common Stock increased to 243,035 shares.
• The RSUs are set to vest on the earlier of the one-year anniversary of the grant date or the date of the Company's 2026 Annual Meeting of Stockholders.
• Vesting is contingent upon Mr. Miller's continued service as a member of the Company's board of directors through the vesting date.

Sentiment

Score: 6

Explanation: The grant of RSUs to a director is a routine compensation event that aligns the director's interests with shareholders, indicating continued commitment. It is generally viewed as a neutral to slightly positive event as it fosters long-term alignment, but does not directly impact immediate operational or financial performance.

Positives

• The grant of Restricted Stock Units (RSUs) to a director aligns their long-term interests with those of the shareholders, incentivizing performance and commitment.
• The increase in beneficial ownership by a director demonstrates continued confidence and investment in the company's future.

Negatives

• The RSU grant represents a potential future dilution for existing shareholders, although it is a common form of executive and director compensation.

Risks

• The vesting of the granted RSUs is contingent upon Brian Christopher Miller's continued service as a director, meaning the shares could be forfeited if his service ceases before the vesting conditions are met.

Future Outlook

The granted Restricted Stock Units (RSUs) are forward-looking, with vesting scheduled for the earlier of the one-year anniversary of the grant or the 2026 Annual Meeting of Stockholders, contingent on the director's continued service.

Industry Context

Equity grants, such as Restricted Stock Units (RSUs), to directors are a standard practice across various industries, including the beauty and health sector. This compensation method is widely used by public companies to align the interests of their board members with long-term shareholder value and to incentivize continued service and performance.

Comparison to Industry Standards

• Granting restricted stock units (RSUs) to directors is a common form of non-cash compensation in publicly traded companies, aligning director incentives with shareholder value.
• The vesting schedule, contingent on continued service, is typical for such equity awards, ensuring retention and long-term commitment, consistent with practices observed in comparable companies within the consumer discretionary and healthcare sectors.

Related Party Transactions

• The grant of 73,051 Restricted Stock Units (RSUs) to Brian Christopher Miller, a director of The Beauty Health Company, constitutes a related party transaction as it involves compensation provided by the company to a member of its board of directors.

Stakeholder Impact

• Shareholders: Potential minor dilution from the issuance of new shares upon RSU vesting, but also increased alignment of a key director's interests with long-term shareholder value.
• Employees: No direct impact mentioned.
• Customers: No direct impact mentioned.
• Suppliers: No direct impact mentioned.
• Creditors: No direct impact mentioned.

Next Steps

• Continued service of Brian Christopher Miller as a director of The Beauty Health Company.
• Vesting of the 73,051 Restricted Stock Units on the earlier of the one-year anniversary of the grant or the 2026 Annual Meeting of Stockholders, subject to continued service.

Key Dates

Keywords

Beauty Health Company, SKIN, Form 4, Insider Transaction, Restricted Stock Units, Equity Grant, Director Compensation, Brian Christopher Miller, Beneficial Ownership